Chinese Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies

ThermoGenesis Corp. KOOL said today that Nanshan Memorial Medical Institute will be utilizing its AXP AutoXpress and BioArchive Systems used to process and store stem cells from cord blood in its two stem cell banks in China. The Nanshan facilities are located in Biolake, Wuhan City, a Hubei provincial government supported hi-tech zone specializing in biotechnology and in Jiuzhou Biotechnology Research Park in Xian City, Shanxi Province. Nanshan expects to procure over time the necessary processing and cryopreservation storage capacity to process and store up to several hundred thousand stem cell units at each facility.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!